Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no visible content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed from the page's revision history. This is a metadata update with no changes to the study content.SummaryDifference0.1%

- Check30 days agoChange DetectedRemoved a banner stating potential information delays due to a lapse in government funding and links to operating-status pages (cc.nih.gov and opm.gov).SummaryDifference0.4%

- Check44 days agoChange DetectedNo additions or deletions detected. The page content remains the same and continues to present the study details.SummaryDifference0.5%

- Check73 days agoChange DetectedOverall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.SummaryDifference3%

- Check80 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.